| Name | Glucocorticoid receptor-IN-2 |
|---|---|
| Synonyms |
Propanamide, N-[(1S,2R)-2-(3,5-difluorophenyl)-1-methyl-2-[[1-(1,2,4-triazolo[4,3-a]pyridin-6-yl)-1H-indazol-5-yl]oxy]ethyl]-2,2-difluoro
Glucocorticoid rector-IN-2 |
| Description | Glucocorticoid receptor-IN-2 (Compound WX019) is a selective glucocorticoid receptor (GR) modulator with anti-inflammatory effect. Glucocorticoid receptor-IN-2 exhibits very good transcriptional repressive activity with an IC50 of 0.171 nM against hMMP1, and comparable transcriptional activation activity with an EC50 of 0.94 nM against MMTV[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Glucocorticoid receptor-IN-2 (Compound WX019) inhibits human peripheral blood mononuclear cells TNF-α with an IC50 of 0.98 nM[1]. Glucocorticoid receptor-IN-2 shows inhibitory effect on CYP3A4 with an IC50 of 9.12 µM[1]. |
| References |
| Molecular Formula | C25H20F4N6O2 |
|---|---|
| Molecular Weight | 512.46 |